The Yuan requests your support! Our content will now be available free of charge for all registered subscribers, consistent with our mission to make AI a human commons accessible to all. We are therefore requesting donations from our readers so we may continue bringing you insightful reportage of this awesome technology that is sweeping the world. Donate now
The Don’t-Go-It-Alone AI Strategy
By Chuck Martin  |  Nov 22, 2021
The Don’t-Go-It-Alone AI Strategy
Image courtesy of and under license from
Never has the saying ‘two heads are better than one’ been more applicable than in trying to utilize the phenomenon of artificial intelligence. Best-selling author Chuck Martin urges businesses to seek outside help to make progress in AI.

NEW YORK - Businesses approaching artificial intelligence (AI) at any level should look outside the walls of their own organizations if they have any expectations of moving forward in a significant way.

The current reality is that the complexity and speed of AI’s evolution can no longer be managed by any one company alone, no matter its industry or resources.

Thus, when IBM was developing its advanced Watson Orchestrate enterprise-level digital assistant, it tapped AI industry leaders in the private community of VisionAIres for feedback and advice. Despite IBM’s size and massive resources, AI leaders there were savvy enough to seek outside viewpoints on their approach, and when global retailer H&M took a company-wide approach to deploying AI, it too brought in outside help.

“We worked with different consultant partners, we had third party consultants, independent contractors and then we had our internal H&M advanced analytics landscape data team,” said Errol Koolmeister, who headed the AI Foundation at H&M and led the AI and tech architecture for the global retailer. “What we did very cleverly was that we consciously picked an external consultancy firm as a strategic partner to help us. While we were building the internal organization, we also worked heavily with strategic partners in building up the technical capabilities.”

In healthcare, collaborations of all sorts are taking shape, often with more than one partnership. AI-powered drug discovery startup Exscientia, e.g., which raised US$160 million in private funding before going public, partnered with Bristol Myers Squibb as one of its

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. Such content from The Yuan may be shared and reprinted but must clearly identify The Yuan as its original source. Content from a third-party copyright holder identified in the copyright notice contained in such third party’s content appearing in The Yuan must likewise be clearly labeled as such.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.